Optinose to Present at the Cantor Virtual Global Healthcare Conference
Optinose (NASDAQ: OPTN), a pharmaceutical company specializing in ear, nose, and throat (ENT) and allergy treatments, has announced that CEO Peter Miller will present a company overview and business update at the Cantor Virtual Global Healthcare Conference on September 16, 2020, at 2:00 p.m. ET. The presentation can be accessed via live webcast on the Optinose investors page, with a replay available for 30 days post-event. For further information, visit www.optinose.com.
- None.
- None.
YARDLEY, Pa., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will present a company overview and business update at the Cantor Virtual Global Healthcare Conference on September 16, 2020, at 2:00 p.m. ET.
To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.
A replay of the webcast will be available for 30 days following the conclusion of the event.
About Optinose
Optinose is a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.
Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531
FAQ
What is the date and time of Optinose's presentation at the Cantor Virtual Global Healthcare Conference?
How can I access the live webcast of the Optinose presentation?
Will there be a replay of the Optinose presentation available after the event?
What is the focus of Optinose as a pharmaceutical company?
